Digital Exclusives
Two alumnae launch into rarefied air with their own female-led venture capital fund for startups healing heath care with digital technology.
Are recent health care mergers a good thing? Who are the winners and losers in these deals? Jeff Voigt finds answers in research on past consolidations.
David Fajgenbaum is battling a little-known, extremely deadly disease as a researcher, a physician, an advocate, an entrepreneur and a patient.
Health Care Management alumni reflect on how and why raising funds for the Kinney Alumni Scholarship was so successful.
As part of the Affordable Care Act, primary care providers got paid more to take Medicaid patients. Did it work to provide better care to more people?
Could health gains from the ACA be in jeopardy from reluctance to continue state-based Medicaid payments? A Wharton Health Care Management alum sounds off.
With upward of 39 million more Americans receiving health care coverage through health care reform, will the system be able to meet the demand?
Wharton alumni are right in the thick of meaty health care issues, like the cost of specialty drugs. Here’s a recap of some notable graduates talking about the topic for SiriusXM.
The Mack Institute hosted its first Innovation Clinic of many to empower thinkers and doers across Penn’s campus.
The health care capabilities of Apple’s ”most personal device ever” could boost a marketplace filled with promising startups, says a medical device specialist.
Health care expert Jeff Voigt looks at a controversial liver drug to illustrate the growing importance of medical cost-effectiveness.
Wharton's own sports medicine pioneer opens up about everything from why he pursued an MBA in his early 50s to how he discovered new treatment options for core muscle injuries.
What does Massachusetts’ decision on Partners Healthcare mean for physicians and their patients? The Wharton Health Care Alumni Association president explains.
A Wharton blogger makes a call for greater transparency for the federal health care agency, particularly when patient outcomes and cost reductions are concerned.
An MBA student comes to grips with the start of his last spring semester at Wharton.
Linda Pavy, WG’80, has had tremendous serendipity with career and life. We ask her why.
